U.S. market Closed. Opens in 1 day 6 hours 38 minutes

DRUG | Bright Minds Biosciences Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-30
RevenueN/AN/AN/AN/AN/A
Cost of Revenue72.45K6.04KN/AN/AN/A
Gross Profit-72.45K-6.04KN/AN/AN/A
Operating Expenses7.21M14.73M8.60M469.36K78.72K
Selling, General & Admin2.21M2.55M2.29M114.51K36.71K
Research & Development5.00M12.18M6.31M354.85K42.01K
Other Operating ExpensesN/A-243.08K-181.74K-5.45KN/A
Operating Income-7.21M-14.74M-8.76M-469.36K-78.72K
Other Expenses / Income-157.29K-232.93K-27.64K-5.45K157.43K
Before Tax Income-7.37M-14.96M-8.65M-480.38K-78.72K
Income Tax ExpensesN/A222.78K-135.43K5.57K-236.00
Net Income-7.37M-15.19M-8.52M-485.94K-78.72K
Interest Expenses19.75K222.78KN/AN/AN/A
Basic Shares Outstanding3.72M2.47M1.79M1.28M1.28M
Diluted Shares Outstanding3.72M2.47M1.79M1.28M1.28M
EBITDA-7.28M-14.96MN/AN/AN/A
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-7.35M-14.74M-8.65M-480.38K-78.95K
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-09-302022-09-302021-09-302020-09-302019-09-30
An error has occurred. This application may no longer respond until reloaded. Reload 🗙